TERT Promoter Mutations and rs2853669 Polymorphism: Useful Markers for Clinical Outcome Stratification of Patients With Oral Cavity Squamous Cell Carcinoma

ObjectiveTo date, no useful prognostic biomarker exists for patients with oral squamous cell carcinoma (OCSCC), a tumour with uncertain biological behaviour and subsequent unpredictable clinical course. We aim to investigate the prognostic significance of two recurrent somatic mutations (-124 C&...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Silvia Giunco, Paolo Boscolo-Rizzo, Enrica Rampazzo, Giancarlo Tirelli, Lara Alessandrini, Roberto Di Carlo, Marco Rossi, Piero Nicolai, Anna Menegaldo, Valentina Carraro, Margherita Tofanelli, Luigia Bandolin, Giacomo Spinato, Enzo Emanuelli, Monica Mantovani, Marco Stellin, Rossana Bussani, Angelo Paolo Dei Tos, Maria Guido, Marzia Morello, Jonathan Fussey, Giovanni Esposito, Jerry Polesel, Anita De Rossi
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/1a7721d701e24121866b2335e5b0aee7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1a7721d701e24121866b2335e5b0aee7
record_format dspace
spelling oai:doaj.org-article:1a7721d701e24121866b2335e5b0aee72021-11-10T05:35:33ZTERT Promoter Mutations and rs2853669 Polymorphism: Useful Markers for Clinical Outcome Stratification of Patients With Oral Cavity Squamous Cell Carcinoma2234-943X10.3389/fonc.2021.782658https://doaj.org/article/1a7721d701e24121866b2335e5b0aee72021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.782658/fullhttps://doaj.org/toc/2234-943XObjectiveTo date, no useful prognostic biomarker exists for patients with oral squamous cell carcinoma (OCSCC), a tumour with uncertain biological behaviour and subsequent unpredictable clinical course. We aim to investigate the prognostic significance of two recurrent somatic mutations (-124 C>T and -146 C>T) within the promoter of telomerase reverse transcriptase (TERT) gene and the impact of TERT single nucleotide polymorphism (SNP) rs2853669 in patients surgically treated for OCSCC.MethodsThe genetic frequencies of rs2853669, -124 C>T and -146 C>T as well as the telomere length were investigated in 144 tumours and 57 normal adjacent mucosal (AM) specimens from OCSCC patients.ResultsForty-five tumours harboured TERT promoter mutations (31.3%), with -124 C>T and -146 C>T accounting for 64.4% and 35.6% of the alterations respectively. Patients with -124 C>T TERT promoter mutated tumours had the shortest telomeres in the AM (p=0.016) and showed higher risk of local recurrence (hazard ratio [HR]:2.75, p=0.0143), death (HR:2.71, p=0.0079) and disease progression (HR:2.71, p=0.0024) with the effect being potentiated by the co-occurrence of T/T genotype of rs2853669.Conclusion-124 C>T TERT promoter mutation as well as the T/T genotype of the rs2853669 SNP are attractive independent prognostic biomarkers in patients surgically treated for OCSCC, with the coexistence of these genetic variants showing a synergistic impact on the aggressiveness of the disease.Silvia GiuncoSilvia GiuncoPaolo Boscolo-RizzoPaolo Boscolo-RizzoEnrica RampazzoGiancarlo TirelliLara AlessandriniRoberto Di CarloMarco RossiPiero NicolaiAnna MenegaldoValentina CarraroMargherita TofanelliLuigia BandolinGiacomo SpinatoGiacomo SpinatoEnzo EmanuelliMonica MantovaniMarco StellinRossana BussaniAngelo Paolo Dei TosMaria GuidoMarzia MorelloJonathan FusseyGiovanni EspositoJerry PoleselAnita De RossiAnita De RossiFrontiers Media S.A.articleoral cavity squamous cell carcinoma (OCSCC)telomeraseTERT promoter mutationsSNP rs2853669telomereprognostic biomarkersNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic oral cavity squamous cell carcinoma (OCSCC)
telomerase
TERT promoter mutations
SNP rs2853669
telomere
prognostic biomarkers
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle oral cavity squamous cell carcinoma (OCSCC)
telomerase
TERT promoter mutations
SNP rs2853669
telomere
prognostic biomarkers
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Silvia Giunco
Silvia Giunco
Paolo Boscolo-Rizzo
Paolo Boscolo-Rizzo
Enrica Rampazzo
Giancarlo Tirelli
Lara Alessandrini
Roberto Di Carlo
Marco Rossi
Piero Nicolai
Anna Menegaldo
Valentina Carraro
Margherita Tofanelli
Luigia Bandolin
Giacomo Spinato
Giacomo Spinato
Enzo Emanuelli
Monica Mantovani
Marco Stellin
Rossana Bussani
Angelo Paolo Dei Tos
Maria Guido
Marzia Morello
Jonathan Fussey
Giovanni Esposito
Jerry Polesel
Anita De Rossi
Anita De Rossi
TERT Promoter Mutations and rs2853669 Polymorphism: Useful Markers for Clinical Outcome Stratification of Patients With Oral Cavity Squamous Cell Carcinoma
description ObjectiveTo date, no useful prognostic biomarker exists for patients with oral squamous cell carcinoma (OCSCC), a tumour with uncertain biological behaviour and subsequent unpredictable clinical course. We aim to investigate the prognostic significance of two recurrent somatic mutations (-124 C>T and -146 C>T) within the promoter of telomerase reverse transcriptase (TERT) gene and the impact of TERT single nucleotide polymorphism (SNP) rs2853669 in patients surgically treated for OCSCC.MethodsThe genetic frequencies of rs2853669, -124 C>T and -146 C>T as well as the telomere length were investigated in 144 tumours and 57 normal adjacent mucosal (AM) specimens from OCSCC patients.ResultsForty-five tumours harboured TERT promoter mutations (31.3%), with -124 C>T and -146 C>T accounting for 64.4% and 35.6% of the alterations respectively. Patients with -124 C>T TERT promoter mutated tumours had the shortest telomeres in the AM (p=0.016) and showed higher risk of local recurrence (hazard ratio [HR]:2.75, p=0.0143), death (HR:2.71, p=0.0079) and disease progression (HR:2.71, p=0.0024) with the effect being potentiated by the co-occurrence of T/T genotype of rs2853669.Conclusion-124 C>T TERT promoter mutation as well as the T/T genotype of the rs2853669 SNP are attractive independent prognostic biomarkers in patients surgically treated for OCSCC, with the coexistence of these genetic variants showing a synergistic impact on the aggressiveness of the disease.
format article
author Silvia Giunco
Silvia Giunco
Paolo Boscolo-Rizzo
Paolo Boscolo-Rizzo
Enrica Rampazzo
Giancarlo Tirelli
Lara Alessandrini
Roberto Di Carlo
Marco Rossi
Piero Nicolai
Anna Menegaldo
Valentina Carraro
Margherita Tofanelli
Luigia Bandolin
Giacomo Spinato
Giacomo Spinato
Enzo Emanuelli
Monica Mantovani
Marco Stellin
Rossana Bussani
Angelo Paolo Dei Tos
Maria Guido
Marzia Morello
Jonathan Fussey
Giovanni Esposito
Jerry Polesel
Anita De Rossi
Anita De Rossi
author_facet Silvia Giunco
Silvia Giunco
Paolo Boscolo-Rizzo
Paolo Boscolo-Rizzo
Enrica Rampazzo
Giancarlo Tirelli
Lara Alessandrini
Roberto Di Carlo
Marco Rossi
Piero Nicolai
Anna Menegaldo
Valentina Carraro
Margherita Tofanelli
Luigia Bandolin
Giacomo Spinato
Giacomo Spinato
Enzo Emanuelli
Monica Mantovani
Marco Stellin
Rossana Bussani
Angelo Paolo Dei Tos
Maria Guido
Marzia Morello
Jonathan Fussey
Giovanni Esposito
Jerry Polesel
Anita De Rossi
Anita De Rossi
author_sort Silvia Giunco
title TERT Promoter Mutations and rs2853669 Polymorphism: Useful Markers for Clinical Outcome Stratification of Patients With Oral Cavity Squamous Cell Carcinoma
title_short TERT Promoter Mutations and rs2853669 Polymorphism: Useful Markers for Clinical Outcome Stratification of Patients With Oral Cavity Squamous Cell Carcinoma
title_full TERT Promoter Mutations and rs2853669 Polymorphism: Useful Markers for Clinical Outcome Stratification of Patients With Oral Cavity Squamous Cell Carcinoma
title_fullStr TERT Promoter Mutations and rs2853669 Polymorphism: Useful Markers for Clinical Outcome Stratification of Patients With Oral Cavity Squamous Cell Carcinoma
title_full_unstemmed TERT Promoter Mutations and rs2853669 Polymorphism: Useful Markers for Clinical Outcome Stratification of Patients With Oral Cavity Squamous Cell Carcinoma
title_sort tert promoter mutations and rs2853669 polymorphism: useful markers for clinical outcome stratification of patients with oral cavity squamous cell carcinoma
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/1a7721d701e24121866b2335e5b0aee7
work_keys_str_mv AT silviagiunco tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT silviagiunco tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT paoloboscolorizzo tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT paoloboscolorizzo tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT enricarampazzo tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT giancarlotirelli tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT laraalessandrini tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT robertodicarlo tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT marcorossi tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT pieronicolai tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT annamenegaldo tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT valentinacarraro tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT margheritatofanelli tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT luigiabandolin tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT giacomospinato tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT giacomospinato tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT enzoemanuelli tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT monicamantovani tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT marcostellin tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT rossanabussani tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT angelopaolodeitos tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT mariaguido tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT marziamorello tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT jonathanfussey tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT giovanniesposito tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT jerrypolesel tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT anitaderossi tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
AT anitaderossi tertpromotermutationsandrs2853669polymorphismusefulmarkersforclinicaloutcomestratificationofpatientswithoralcavitysquamouscellcarcinoma
_version_ 1718440534286008320